S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
NYSE:STE

STERIS Stock Competitors

$234.52
-0.33 (-0.14%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$232.43
$235.99
50-Day Range
$215.64
$245.17
52-Week Range
$170.36
$248.29
Volume
424,900 shs
Average Volume
473,280 shs
Market Capitalization
$23.46 billion
P/E Ratio
83.76
Dividend Yield
0.73%
Beta
0.64

STERIS (NYSE:STE) Vs. ABT, MDT, ISRG, SYK, BDX, EW, BSX, IDXX, DXCM, and BAX

Should you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), and Baxter International (BAX). These companies are all part of the "health care equipment" industry.

STERIS vs.

STERIS (NYSE:STE) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, community ranking, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Medtronic received 1256 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 79.06% of users gave Medtronic an outperform vote while only 60.04% of users gave STERIS an outperform vote.

CompanyUnderperformOutperform
STERISOutperform Votes
296
60.04%
Underperform Votes
197
39.96%
MedtronicOutperform Votes
1552
79.06%
Underperform Votes
411
20.94%

89.2% of STERIS shares are owned by institutional investors. Comparatively, 79.0% of Medtronic shares are owned by institutional investors. 1.1% of STERIS shares are owned by company insiders. Comparatively, 0.5% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

STERIS presently has a consensus target price of $248.80, suggesting a potential upside of 6.09%. Medtronic has a consensus target price of $134.81, suggesting a potential upside of 24.19%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than STERIS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STERIS
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Medtronic
0 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.64

Medtronic has higher revenue and earnings than STERIS. Medtronic is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STERIS$3.11 billion7.55$397.40 million$2.8083.76
Medtronic$30.12 billion4.85$3.61 billion$3.4731.28

STERIS pays an annual dividend of $1.72 per share and has a dividend yield of 0.7%. Medtronic pays an annual dividend of $2.52 per share and has a dividend yield of 2.3%. STERIS pays out 61.4% of its earnings in the form of a dividend. Medtronic pays out 72.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Medtronic has a net margin of 14.80% compared to STERIS's net margin of 6.50%. Medtronic's return on equity of 14.52% beat STERIS's return on equity.

Company Net Margins Return on Equity Return on Assets
STERIS 6.50% 12.44% 7.02%
Medtronic 14.80% 14.52% 8.01%

STERIS has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.

In the previous week, Medtronic had 19 more articles in the media than STERIS. MarketBeat recorded 22 mentions for Medtronic and 3 mentions for STERIS. STERIS's average media sentiment score of 0.44 beat Medtronic's score of 0.35 indicating that STERIS is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STERIS
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Medtronic
5 Very Positive mention(s)
7 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Medtronic beats STERIS on 13 of the 20 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STERIS (NYSE:STE) vs. Its Competitors

TypeSTERISSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$23.46B$9.82B$4.68B$15.59B
Dividend Yield0.73%1.21%1.99%3.18%
P/E Ratio83.7621.8516.9022.72
Price / Sales7.5512.326,111.8226.08
Price / Cash26.7129.1062.8384.56
Price / Book5.149.058.0712.17
Net Income$397.40M$144.29M$97.42M$393.64M
7 Day Performance1.30%-3.34%1.53%0.58%
1 Month Performance0.85%-2.94%111.96%2.43%
1 Year Performance27.19%-22.86%130.87%16.47%

STERIS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABT
Abbott Laboratories
2.7777 of 5 stars
$128.16
-1.2%
$139.11
-8.5%
+15.1%$226.62B$34.61B31.80109,000
MDT
Medtronic
3.4136 of 5 stars
$108.55
-0.2%
$134.81
-24.2%
-7.1%$145.95B$30.12B31.2890,000Short Interest ↑
ISRG
Intuitive Surgical
1.8985 of 5 stars
$307.74
-1.8%
$340.81
-10.7%
+18.6%$109.94B$4.36B66.428,081Upcoming Earnings
Analyst Revision
SYK
Stryker
3.1469 of 5 stars
$266.71
-0.4%
$293.85
-10.2%
+10.2%$100.58B$14.35B53.6643,000Short Interest ↑
BDX
Becton, Dickinson and
2.665 of 5 stars
$262.62
-0.4%
$272.43
-3.7%
+0.3%$74.86B$20.25B38.3470,000Positive News
EW
Edwards Lifesciences
2.382 of 5 stars
$118.26
-1.9%
$126.22
-6.7%
+34.6%$73.83B$4.39B50.3214,900Insider Selling
BSX
Boston Scientific
2.3414 of 5 stars
$44.86
-0.6%
$49.90
-11.2%
+23.5%$63.93B$9.91B61.4538,000
IDXX
IDEXX Laboratories
2.4031 of 5 stars
$529.35
-0.9%
$686.40
-29.7%
+8.1%$44.89B$2.71B60.649,300
DXCM
DexCom
2.7607 of 5 stars
$447.34
-1.9%
$586.21
-31.0%
+26.3%$43.36B$1.93B85.536,400Analyst Revision
BAX
Baxter International
2.9927 of 5 stars
$85.74
-0.2%
$95.30
-11.1%
+7.1%$42.93B$11.67B35.8750,000
RMD
ResMed
1.9965 of 5 stars
$252.16
-0.2%
$254.00
-0.7%
+19.2%$36.75B$3.20B73.957,970
HOLX
Hologic
2.5075 of 5 stars
$69.59
-0.5%
$86.33
-24.1%
-8.6%$17.50B$5.63B9.676,705
PODD
Insulet
2.1637 of 5 stars
$242.71
-0.1%
$313.88
-29.3%
-13.7%$16.74B$904.40M-539.361,900
TFX
Teleflex
2.9465 of 5 stars
$325.75
-1.3%
$412.40
-26.6%
-16.1%$15.26B$2.54B35.6014,000
ABMD
Abiomed
2.2064 of 5 stars
$301.22
-1.8%
$375.50
-24.7%
-8.6%$13.70B$847.52M92.971,725
MASI
Masimo
2.3231 of 5 stars
$233.08
-2.0%
$308.33
-32.3%
-10.8%$12.87B$1.14B58.125,300
GMED
Globus Medical
2.5673 of 5 stars
$73.45
-0.6%
$88.45
-20.4%
+15.4%$7.41B$789.04M40.582,200
IART
Integra LifeSciences
2.014 of 5 stars
$68.79
-0.7%
$77.38
-12.5%
+1.6%$5.83B$1.37B27.083,700
ATRC
AtriCure
2.2971 of 5 stars
$65.44
-2.3%
$86.29
-31.9%
+15.6%$3.01B$206.53M68.88750
NUVA
NuVasive
2.2914 of 5 stars
$56.06
-0.0%
$66.60
-18.8%
-1.6%$2.90B$1.05B-109.922,700
ITGR
Integer
2.4281 of 5 stars
$84.46
-2.8%
$108.00
-27.9%
+6.0%$2.79B$1.07B31.637,500
ATEC
Alphatec
2.4148 of 5 stars
$12.21
-0.6%
$18.83
-54.2%
-14.3%$1.21B$144.86M-8.54296
ANGO
AngioDynamics
2.3181 of 5 stars
$22.63
-0.8%
$32.00
-41.4%
+25.7%$876.17M$291.01M-22.86800Gap Down
CSII
Cardiovascular Systems
2.0219 of 5 stars
$19.18
-5.8%
$43.40
-126.3%
-57.1%$777.77M$258.97M-37.61779Short Interest ↑
High Trading Volume
CRY
CryoLife
2.6248 of 5 stars
$19.15
-2.7%
$32.00
-67.1%
-21.0%$753.17M$253.23M638.551,200Gap Down
SRDX
Surmodics
2.2314 of 5 stars
$47.06
-2.3%
$70.00
-48.7%
+7.0%$657.66M$105.14M156.87370Short Interest ↑
News Coverage
Negative News
OFIX
Orthofix Medical
1.4931 of 5 stars
$32.90
-0.0%
N/A-24.7%$649.61M$406.56M-42.731,036
ARAY
Accuray
2.6214 of 5 stars
$4.24
-4.7%
$7.50
-76.9%
-10.7%$385.50M$396.29M-53.00932
IVC
Invacare
1.8031 of 5 stars
$2.76
-2.2%
$8.50
-208.0%
-71.6%$96.66M$850.69M-1.823,400
RMTI
Rockwell Medical
1.6781 of 5 stars
$0.47
-0.1%
$5.00
-968.4%
-61.0%$43.98M$62.20M-1.38300Gap Down
This page was last updated on 1/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.